Literature DB >> 19230204

Evaluation and performance characteristics of the coagulation system: ACL TOP analyzer - HemosIL reagents.

M Milos1, D Herak, L Kuric, I Horvat, R Zadro.   

Abstract

ACL TOP is a fully automated coagulation analyzer, designed for simultaneous measurement of routine and special coagulation parameters. We evaluated analytical and technical performance characteristics of the coagulation system composed of the ACL TOP analyzer and HemosIL reagent group for the determination of routine clotting (PT, APTT, fibrinogen, FVII, and FVIII), chromogenic (protein C) and immunological assays (FXIII antigen). Within run and between run CVs ranged from 0.9% to 7.7% and from 2.0% to 14.8% respectively. The obtained CVs for imprecision of calibration curves were <5% of PT and <7% for fibrinogen. The method comparison study showed good correlation between results obtained on the ACL TOP and BCS/BCT analyzers, with correlation co-efficients ranging from 0.709 to 0.955, but with significantly different results for PT INR, APTT, fibrinogen and protein C, and wide dispersion of differences observed in difference plots for most assays. Despite good correlation and agreement for FVIII, problems in measuring FVIII<10% were encountered. The effective througput for the ACL TOP and BCS was 151 and 212 PT/APTT/fibrinogen tests per hour, respectively. Although the ACL TOP is designed to run multiple assays on a large number of samples, software limitations make the instrument suitable rather for mid-sized laboratories.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19230204     DOI: 10.1111/j.1751-553x.2007.00999.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  9 in total

1.  Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran.

Authors:  Paul K L Chin; David M Patterson; Mei Zhang; Berit P Jensen; Daniel F B Wright; Murray L Barclay; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

Review 2.  Diagnostic testing and interpretation of tests for autoimmunity.

Authors:  Christine Castro; Mark Gourley
Journal:  J Allergy Clin Immunol       Date:  2010-01-12       Impact factor: 10.793

3.  Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono- and dual-antiplatelet therapy.

Authors:  Kevin Bliden; Rahul Chaudhary; Athan Kuliopulos; Henry Tran; Hamid Taheri; Behnam Tehrani; Arnold Rosenblatt; Eliano Navarese; Udaya S Tantry; Paul A Gurbel
Journal:  J Thromb Haemost       Date:  2019-09-17       Impact factor: 5.824

4.  Impact of experimental hypercalcemia on routine haemostasis testing.

Authors:  Giuseppe Lippi; Gian Luca Salvagno; Giorgio Brocco; Matteo Gelati; Elisa Danese; Emmanuel J Favaloro
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

5.  Utility of Clot Waveform Analysis in Russell's Viper Bite Victims with Hematotoxicity.

Authors:  Siju V Abraham; Aboobacker Mohamed Rafi; S Vimal Krishnan; Babu Urumese Palatty; Susheela J Innah; Jerry Johny; Salish Varghese
Journal:  J Emerg Trauma Shock       Date:  2018 Jul-Sep

6.  Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity.

Authors:  Martina Leitner; Christian Büchold; Ralf Pasternack; Nikolaus B Binder; Gary W Moore
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

7.  A Comparative Evaluation of an Automated Functional Assay for Von Willebrand Factor Activity in Type 1 Von Willebrand Disease.

Authors:  Shiue-Wei Lai; Chia-Yau Chang; Shin-Nan Cheng; Shu-Hsia Hu; Chung-Yu Lai; Yeu-Chin Chen
Journal:  Int J Gen Med       Date:  2021-09-02

8.  The Sysmex CS-5100 coagulation analyzer offers comparable analytical performance and excellent throughput capabilities.

Authors:  T Flieder; T Gripp; C Knabbe; I Birschmann
Journal:  Pract Lab Med       Date:  2016-09-21

9.  System performance evaluation of the cobas t 711 and cobas t 511 coagulation analyzers in routine laboratory settings.

Authors:  Steve Kitchen; Moniek de Maat; Michael Nagler; Robert Jones; Anna Lowe; John Burden; Kai Groneberg; Gergely Rozsnyai
Journal:  Blood Coagul Fibrinolysis       Date:  2020-10       Impact factor: 1.061

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.